NCT01453153 2018-11-30
Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
Halozyme Therapeutics
Phase 1/2 Completed
Halozyme Therapeutics
Merck KGaA, Darmstadt, Germany
BioRegen Biomedical (CHangzhou) Co., Ltd